Pfizer Company - Search News

Starboard Takes $1B Stake In Pfizer

The Motley Fool on MSN · 34m

As a Billionaire Activist Takes a Stake, Is Now the Time to Buy Pfizer Stock?

Shares of Pfizer (NYSE: PFE) have been stuck in the mud since December 2022, with its shares down more than 45% over that stretch. Despite its underwhelming performance, many individual investors are attracted to the drug giant's robust dividend,

Activist investor takes $1B stake in Pfizer, aims to turn around company

Citing people familiar with the matter, The Journal reported that Starboard approached former Pfizer CEO Ian Read and CFO Frank D’Amelio to assist in its plans.

BioSpace · 19h

Activist Investor Starboard Carves $1B Stake in Pfizer, Enlists Former CEO for Help

Pfizer in recent months has implemented aggressive cost-cutting measures to help it weather the steep decline in sales of its COVID-19 products.

GSK, Pfizer RSV vaccine sales fall in US

GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and said it was a once-in-a-lifetime shot for now, excluding millions of people who got one last year.

Pfizer Wins London Court Battle, GSK's Respiratory Syncytial Virus Vaccine Patents Invalidated

Pfizer Inc. (NYSE:PFE) stock is trading higher with a session volume of 31.16 million as per data from Benzinga Pro. Activist investor Starboard Value has invested approximately $1 billion in Pfizer as the pharmaceutical giant grapples with a downturn in demand for COVID-19 vaccines and treatments.

Seeking Alpha · 1d

U.K. court rules in Pfizer's favor in GSK RSV vaccine dispute: report

Pfizer (PFE) has reportedly succeeded in getting a U.K. court to invalidate two of GSK’s (GSK) patents for its RSV vaccine. Read more here.

20hon MSN

Pfizer CEO’s Job Is at Risk. A Shot of Discipline Could Help.

As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.

22h

Pfizer: A 6% Yielding Ultra SWAN Bargain With Upside Potential

Pfizer (PFE) stock may present opportunities for patient investors. Read how this biotech giant may deliver long-term ...

FiercePharma14h

Pfizer, bracing for Hurricane Milton, pledges aid to emergency services and health support

Is your company bracing for Milton or working to provide aid in anticipation of the storm? | Pfizer—which opened a global hub ...

5d

Is Pfizer a Buy Right Now or a Value Trap?

On top of this, Pfizer also faces key patent expirations of certain older products, and earlier estimated this will result in ...

1d

Pfizer: A Strong Product Pipeline Could Lead To Significant Upside

Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...

1d

Meet Jeff Smith, the hedge-fund investor taking on Pfizer

Since 2011, Starboard Value's Jeff Smith has extracted board seats and profits from corporate America — by force if necessary ...

6hon MSN

Pfizer CEO Albert Bourla Set To Meet Activist Investor Starboard Value As Pressure Mounts To Revitalize Struggling Stock: Report

CEO Albert Bourla is set to meet with activist investor Starboard Value amid growing pressure to revitalize the ...

1d

Why Pfizer Stock Popped on Monday

Pfizer (NYSE: PFE) stock jumped 3.1% through 11:20 a.m. ET Monday morning in response to a Wall Street Journal article over ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results